« How much avian flu vaccine does Africa need? | Main | New uses for old drugs »

Bookmark in Connotea

Clinical setbacks for toll-like receptor 9 agonists in cancer

With disappointing results in the clinic against cancer, are toll-like receptor agonists likely to be useful for protecting against viral diseases such as influenza?

See the full story here

Posted by Julie Clayton on August 21, 2007
Categories: | | Comments (0) | TrackBacks (0)

TrackBack

TrackBack URL for this entry:
http://blogs.nature.com/cgi-bin/mt/mt-tb.cgi/3269

Post a comment

Comments will be reviewed by the blog editors before being published, mainly to ensure that spam and irrelevant material (such as product advertisements) are not published . Please keep your comment brief. Excessively long or offensively phrased entries will be edited.

We strongly encourage you to use your real, full name. E-mail addresses are required in case we need to discuss your comment with you directly. We won't publish your e-mail address unless you request it.

Please enter the numbers you see below - this helps us to avoid spam. If you are having trouble with this system, you can send your comment by e-mail to 'avianflu at nature.com'.

please enter code